Publication | Open Access

Efficacy of boceprevir, an NS3 protease inhibitor, in combination with peginterferon alfa-2b and ribavirin in treatment-naive patients with genotype 1 hepatitis C infection (SPRINT-1): an open-label, randomised, multicentre phase 2 trial

HepatologyHepatitis CViral HepatitisNs3 Protease InhibitorAntiviral Drug DevelopmentAntiviral TherapyHepatitisVirologyInfection ControlHepatitis C InfectionAntiviral DrugMedicineGenotype 1